Disruption of a DNA loop as a complementary mechanism of H3.3K27M mutations

DNA 环的破坏作为 H3.3K27M 突变的补充机制

基本信息

项目摘要

Somatic histone mutations are a hallmark of pediatric high-grade gliomas (pHGGs). Recurrent mutations in the genes encoding for histone variants H3.3 (H3F3A) and H3.1 (HIST1H3B, HIST1H3C) lead to amino acid substitutions at two key residues in the histone tail: lysine to methionine at position 27 (K27M) and glycine to arginine or valine at position 34 (G34R/V). H3.3K27M mutations are associated with distinct clinicopathological characteristics, such as anatomical distribution of tumors carrying these mutations, histological features, age at presentation and survival time. Although great progress has been made in understanding the inhibition of methyltransferases by K27M mutations, additional molecular mechanisms that contribute to the overall poor survival of H3.3K27M pHGG patients may have been overlooked. By DNA sequence analysis, we have recently predicted that the H3.3K27M mutation simultaneously disrupts the K27 codon of the H3F3A gene and the core unit of a DNA binding motif, which is recognized by the DNA-binding protein CCCTC-binding factor (CTCF). Preliminary chromatin immunoprecipitation data in patient derived pHGG cell lines and primary pHGG tumors indicate that CTCF indeed binds the H3F3A wild type, but not the H3.3K27M mutant allele. Based on our compelling preliminary results, we now propose the central hypothesis that the exonic CTCF binding site plays a critical role in the regulation of DNA loops and gene expression, and the disruption of the CTCF binding site by H3.3K27M mutations contributes to gliomagenesis. Toward this objective, we propose: (i) To validate the effects of the mutated CTCF binding site on the disruption of DNA loops and enhancer-mediated misregulation nearby genes in primary pHGG tumors and patient derived pHGGs cell lines (Aim 1); (ii) To validate the relevance of the disrupted exonic CTCF binding site for early transformation leading to pHGGs. We aim to generate targeted induced pluripotent stem cells (iPSCs) by replacing the endogenous H3F3A allele with a wildtype H3.3 sequence (H3.3-CTCF+) fused to an inducible H3.3 version with synonymous nucleotide substitutions (H3.3-CTCF-). Synonymous H3.3-CTCF- substitutions disrupt the CTCF binding site while retaining the wild-type H3F3A amino acid sequence. Targeted isogenic iPSCs will be differentiated into different cell types of the neural lineage, including oligodendroglial precursor cells (OPCs), and assessed for relative changes in proliferation, apoptosis, and differentiation in induced H3.3-CTCF- compared to uninduced H3.3-CTCF+ cells (Aim 2). Upon conclusion, we will have functionally tested the influence of the mutated exonic CTCF binding site on chromosome conformation, gene regulation, and impaired differentiation into OPCs as an additional molecular mechanism of H3.3K27M gliomagenesis.
体细胞蛋白突变是小儿高级神经胶质瘤(PHGGS)的标志。复发突变 编码组蛋白变异的基因H3.3(H3F3A)和H3.1(Hist1h3b,Hist1h3c)导致氨基酸 在组蛋白尾部的两个关键残基上取代:赖氨酸至27(k27m)的蛋氨酸,甘氨酸和甘氨酸 位置34(G34R/V)处的精氨酸或瓣膜。 H3.3K27M突变与不同的临床病理学有关 特征,例如携带这些突变的肿瘤的解剖学分布,组织学特征,年龄 表现和生存时间。尽管在理解抑制方面取得了巨大进展 通过K27M突变,甲基转移酶,促成整体较差的其他分子机制 H3.3K27M PHGG患者的生存率可能被忽略了。 通过DNA序列分析,我们最近预测,H3.3K27M突变同时破坏了 H3F3A基因的K27密码子和DNA结合基序的核心单位,该基序是由DNA结合所识别的 蛋白CCCTC结合因子(CTCF)。患者衍生的PHGG中的初步染色质免疫沉淀数据 细胞系和原发性PHGG肿瘤表明CTCF确实结合了H3F3A野生型,但不结合H3.3K27M 突变等位基因。 基于我们引人注目的初步结果,我们现在提出了一个中心假设,即外显子CTCF 结合位点在DNA环和基因表达的调节中起着至关重要的作用,并且破坏了 H3.3K27M突变的CTCF结合位点有助于神经胶质作用。朝向这个目标,我们提出:(i) 验证突变的CTCF结合位点对DNA环和增强子介导的破坏的影响 原发性PHGG肿瘤和患者衍生的PHGGS细胞系中附近基因附近的正调(AIM 1); (ii)验证 破坏的外显子CTCF结合位点的相关性对于早期转化导致PHGG的相关性。我们的目标 通过用A替换内源性H3F3A等位基因,生成靶向诱导的多能干细胞(IPSC) WildType H3.3序列(H3.3-CTCF+)融合到具有同义核苷酸的诱导H3.3版本 取代(H3.3-CTCF-)。保留时,同义H3.3-CTCF-替换破坏了CTCF绑定位点 野生型H3F3A氨基酸序列。靶向的ISEGENIC IPSC将分为不同的细胞类型 神经谱系,包括寡头前体细胞(OPC),并评估了相对变化 与未诱导的H3.3-CTCF+细胞相比,诱导H3.3-CTCF-的增殖,凋亡和分化 (目标2)。总结一下,我们将在功能上测试突变的外显子CTCF结合位点的影响 关于染色体构象,基因调节和分化为OPC的损害 H3.3K27M神经胶质作用的分子机制。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.
  • DOI:
    10.1038/s41467-023-38044-0
  • 发表时间:
    2023-04-21
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Okonechnikov, Konstantin;Camgoez, Aylin;Chapman, Owen;Wani, Sameena;Park, Donglim Esther;Huebner, Jens-Martin;Chakraborty, Abhijit;Pagadala, Meghana;Bump, Rosalind;Chandran, Sahaana;Kraft, Katerina;Acuna-Hidalgo, Rocio;Reid, Derek;Sikkink, Kristin;Mauermann, Monika;Juarez, Edwin F.;Jenseit, Anne;Robinson, James T.;Pajtler, Kristian W.;Milde, Till;Jaeger, Natalie;Fiesel, Petra;Morgan, Ling;Sridhar, Sunita;Coufal, Nicole G.;Levy, Michael;Malicki, Denise;Hobbs, Charlotte;Kingsmore, Stephen;Nahas, Shareef;Snuderl, Matija;Crawford, John;Wechsler-Reya, Robert J.;Davidson, Tom Belle;Cotter, Jennifer;Michaiel, George;Fleischhack, Gudrun;Mundlos, Stefan;Schmitt, Anthony;Carter, Hannah;Michealraj, Kulandaimanuvel Antony;Kumar, Sachin A.;Taylor, Michael D.;Rich, Jeremy;Buchholz, Frank;Mesirov, Jill P.;Pfister, Stefan M.;Ay, Ferhat;Dixon, Jesse R.;Kool, Marcel;Chavez, Lukas
  • 通讯作者:
    Chavez, Lukas
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lukas Chavez其他文献

Lukas Chavez的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lukas Chavez', 18)}}的其他基金

Transcriptional activation of RCOR2 as a novel oncogenic mechanism in supratentorial ependymoma
RCOR2的转录激活作为幕上室管膜瘤的新型致癌机制
  • 批准号:
    10762312
  • 财政年份:
    2023
  • 资助金额:
    $ 2.2万
  • 项目类别:
Transcriptional activation of LAMC1 as a resistance mechanism in recurrent PFA Ependymoma
LAMC1 的转录激活作为复发性 PFA 室管膜瘤的耐药机制
  • 批准号:
    10762310
  • 财政年份:
    2023
  • 资助金额:
    $ 2.2万
  • 项目类别:
Investigation of ecDNA as a driver of intratumoral heterogeneity and treatment resistance in high-risk medulloblastoma
EcDNA 作为高危髓母细胞瘤瘤内异质性和治疗耐药性驱动因素的研究
  • 批准号:
    10709196
  • 财政年份:
    2023
  • 资助金额:
    $ 2.2万
  • 项目类别:
Transcriptional activation of LAMC1 as a resistance mechanism in recurrent PFA Ependymoma
LAMC1 的转录激活作为复发性 PFA 室管膜瘤的耐药机制
  • 批准号:
    10308691
  • 财政年份:
    2020
  • 资助金额:
    $ 2.2万
  • 项目类别:

相似国自然基金

SWI/SNF复合体抑制R-Loop诱导的DNA损伤及对耐药肿瘤靶向治疗的应用
  • 批准号:
    82303636
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
真核生物DNA复制速率对R-loop和基因组(端粒)稳定性的影响
  • 批准号:
    32161133015
  • 批准年份:
    2021
  • 资助金额:
    300 万元
  • 项目类别:
DNA修复缺陷通过R-loop/STRs结构影响肺癌新生抗原质量的机制研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
超级增强子源cirRNA-EYA3作为ceRNA调控ATM—DNA损伤通路参与肝癌对125I放射抵抗的机制研究
  • 批准号:
    81871467
  • 批准年份:
    2018
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目

相似海外基金

Chromatin Domain Dynamics
染色质域动力学
  • 批准号:
    7261122
  • 财政年份:
    2007
  • 资助金额:
    $ 2.2万
  • 项目类别:
Chromatin Domain Dynamics
染色质域动力学
  • 批准号:
    7365099
  • 财政年份:
    2007
  • 资助金额:
    $ 2.2万
  • 项目类别:
Structural and functional analyses of archaeal sRNPs
古菌 sRNP 的结构和功能分析
  • 批准号:
    7265306
  • 财政年份:
    2005
  • 资助金额:
    $ 2.2万
  • 项目类别:
Single molecule studies of nucleosomes and transcription
核小体和转录的单分子研究
  • 批准号:
    7219529
  • 财政年份:
    1999
  • 资助金额:
    $ 2.2万
  • 项目类别:
BWS and Embryonal Tumor Suppressor Genes on 11p15
BWS 和胚胎肿瘤抑制基因 11p15
  • 批准号:
    7409136
  • 财政年份:
    1991
  • 资助金额:
    $ 2.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了